Exabis Library
Welcome to the e-CCO Library!
P266: Elderly-onset Inflammatory Bowel Disease: a retrospective single-center study with current follow-up
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P266: First step towards validation of the Quality of Working Life Questionnaire (QWLQ) in inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P266: How disease extent can be included in the Endoscopic Activity Index of ulcerative colitis: the pan Mayo score, a promising scoring system
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P266: Potential oral microbial markers for differential diagnosis of Crohn's disease and ulcerative colitis using machine learning model
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P266: Risk factors for colorectal neoplasia in ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P266: The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients: a real-life multicentric cohort study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P267 Validation of the short inflammatory bowel disease questionnaire as an outcome measure in Crohn’s disease patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P267: Are ulcerative colitis outpatients at nutritional risk?
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P267: Candidate serum markers in newly diagnosed Crohn's disease patients
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P267: Long-term outcome of anti-TNF therapy in children with Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P267: Milan Ultrasound Criteria are accurate in assessing endoscopic remission and treatment response in patients with ulcerative colitis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P267: Real-world artificial intelligence-aided colonoscopy does not improve adenoma detection rates in patients with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P267: Relationship between morphological alteration of paneth cells and dysbiosis in patients with inflammatory bowel disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P267: Sequencing of anti-TNF agents and gut-selective anti-lymphocyte trafficking (GSALT) therapy in the treatment of Crohn’s disease (CD)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P268 Systematic review and meta-analysis: Inflammatory bowel disease (IBD) associated colonic dysplasia prognosis in the video-endoscopic era
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P268: A questionnaire on the diagnosis of microscopic colitis in Denmark
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P268: Development and validation of a novel composite index for the assessment of endoscopic and histologic disease activity in pouchitis: The Atlantic pouchitis index.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P268: Eosinophil-derived neurotoxin (eosinophil protein x) showed higher specificity and positive predictive value for detecting disease activity in inflammatory bowel disease compare to faecal calprotectin
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P268: Fecal calprotectin correlates more highly with endoscopic disease activity than symptom-based disease activity markers in paediatric PSC-IBD
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P268: IBD and Covid-19 in italy: comparisons between first and second pandemic wave
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM